Type IV Bartter syndrome: Report of two new cases

Marco Zaffanello, Anna Taranta, Alessia Palma, Alberto Bettinelli, Gian Luigi Marseglia, Francesco Emma

Research output: Contribution to journalArticlepeer-review


Bartter syndrome with sensorineural deafness (type IV Bartter syndrome) is a subtype of this tubular disease, and is due to mutations in the BSND gene. Out of a population of 92 patients with Bartter syndrome, five suffered from mild to severe hypoacusia and were selected for mutational screening. A homozygous mutation in the BSND gene was found in two female patients. The first patient was found to have a substitution in intron 1 donor splice site at position +5 (c.420+5G>C), whereas the second patient has a homozygous 3G>A substitution leading to the loss of the start codon for the translation of the BSND mRNA. The clinical courses of these two patients were remarkable for severe polyhydramnios, massive renal salt and water wasting, severe neonatal hypotonia, poor growth and unresponsiveness to prostaglandin inhibitors. The diuretic responses to furosemide and to hydrochlorothiazide were tested under KCl supplementation in one patient. A lack of response to both drugs suggested that inhibition of NaCl reabsorption in type IV Bartter syndrome is not restricted to the thick ascending limb of Henle. In one patient, a combined therapy with indomethacin and captopril was needed to discontinue intravenous fluids and improve weight gain.

Original languageEnglish
Pages (from-to)766-770
Number of pages5
JournalPediatric Nephrology
Issue number6
Publication statusPublished - Jun 2006


  • Bartter syndrome
  • Captopril
  • Furosemide
  • Hydrochlorothiazide
  • Indomethacin
  • Nimesulide
  • Sensorineural deafness

ASJC Scopus subject areas

  • Nephrology
  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Type IV Bartter syndrome: Report of two new cases'. Together they form a unique fingerprint.

Cite this